Relationship Between Platinum Levels in the Blood and Neurotoxicity in Patients Who Are Receiving Oxaliplatin for Gastrointestinal Cancer NCT00274885 Cancer
oxaliplatin
management of t...
18 Years - National Cancer Institute (NCI) View Family Caregiver Palliative Care Intervention in Supporting Caregivers of Patients With Stage II-IV Gastrointestinal, Gynecologic, Urologic and Lung Cancers NCT01846520 Healthy Subject
Localized Trans...
Metastatic Tran...
Psychosocial Ef...
Recurrent Bladd...
Recurrent Cervi...
Recurrent Colon...
Recurrent Gastr...
Recurrent Ovari...
Recurrent Ovari...
Recurrent Pancr...
Recurrent Recta...
Recurrent Renal...
Recurrent Trans...
Recurrent Ureth...
Recurrent Uteri...
Regional Transi...
Stage II Bladde...
Stage II Renal ...
Stage II Urethr...
Stage IIA Cervi...
Stage IIA Colon...
Stage IIA Gastr...
Stage IIA Ovari...
Stage IIA Ovari...
Stage IIA Pancr...
Stage IIA Recta...
Stage IIA Uteri...
Stage IIB Cervi...
Stage IIB Colon...
Stage IIB Gastr...
Stage IIB Ovari...
Stage IIB Ovari...
Stage IIB Pancr...
Stage IIB Recta...
Stage IIB Uteri...
Stage IIC Colon...
Stage IIC Ovari...
Stage IIC Ovari...
Stage IIC Recta...
Stage III Bladd...
Stage III Pancr...
Stage III Renal...
Stage III Ureth...
Stage IIIA Cerv...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIA Ovar...
Stage IIIA Ovar...
Stage IIIA Rect...
Stage IIIA Uter...
Stage IIIB Cerv...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIB Ovar...
Stage IIIB Ovar...
Stage IIIB Rect...
Stage IIIB Uter...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Ovar...
Stage IIIC Ovar...
Stage IIIC Rect...
Stage IIIC Uter...
Stage IV Bladde...
Stage IV Gastri...
Stage IV Ovaria...
Stage IV Ovaria...
Stage IV Pancre...
Stage IV Renal ...
Stage IV Urethr...
Stage IVA Cervi...
Stage IVA Colon...
Stage IVA Recta...
Stage IVA Uteri...
Stage IVB Cervi...
Stage IVB Colon...
Stage IVB Recta...
Stage IVB Uteri...
Ureter Cancer
Stage IIA Lung ...
Stage IIB Lung ...
Stage IIIA Lung...
Stage IIIB Lung...
educational int...
telephone-based...
quality-of-life...
questionnaire a...
18 Years - City of Hope Medical Center View 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer NCT01939275 Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IA Gastri...
Stage IB Gastri...
Stage IIA Gastr...
Stage IIB Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
copper Cu 64-DO...
positron emissi...
laboratory biom...
Computed Tomogr...
18 Years - City of Hope Medical Center View Docetaxel, Oxaliplatin, Capecitabine, Fluorouracil, and Radiation Therapy in Treating Patients With Locally Advanced Cancer of the Esophagus or Gastroesophageal Junction NCT00938470 Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
capecitabine
docetaxel
fluorouracil
oxaliplatin
radiation thera...
therapeutic con...
18 Years - Alliance for Clinical Trials in Oncology View S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer NCT01498289 Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
FOLFOX regimen
docetaxel
fluorouracil
irinotecan hydr...
leucovorin calc...
oxaliplatin
18 Years - 120 Years SWOG Cancer Research Network View 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer NCT01939275 Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IA Gastri...
Stage IB Gastri...
Stage IIA Gastr...
Stage IIB Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
copper Cu 64-DO...
positron emissi...
laboratory biom...
Computed Tomogr...
18 Years - City of Hope Medical Center View Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer NCT01212822 Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Squamous Cell C...
Stage IA Esopha...
Stage IA Gastri...
Stage IB Esopha...
Stage IB Gastri...
Stage IIA Esoph...
Stage IIA Gastr...
Stage IIB Esoph...
Stage IIB Gastr...
Stage IIIA Esop...
Stage IIIA Gast...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
therapeutic con...
laboratory biom...
18 Years - Fox Chase Cancer Center View Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer NCT00978549 Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
Nausea and Vomi...
Pain
docetaxel
steroid therapy
questionnaire a...
nausea and vomi...
pain therapy
quality-of-life...
standard follow...
radiation thera...
18 Years - National Cancer Institute (NCI) View Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies NCT01643499 Acinar Cell Ade...
Adenocarcinoma ...
Adenocarcinoma ...
Adult Primary C...
Advanced Adult ...
Cholangiocarcin...
Cholangiocarcin...
Diffuse Adenoca...
Duct Cell Adeno...
Intestinal Aden...
Localized Unres...
Metastatic Carc...
Metastatic Extr...
Mixed Adenocarc...
Mucinous Adenoc...
Mucinous Adenoc...
Newly Diagnosed...
Signet Ring Ade...
Signet Ring Ade...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Gall...
Stage IIIA Gast...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Gall...
Stage IIIB Gast...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Rect...
Stage IV Gastri...
Stage IV Pancre...
Stage IVA Colon...
Stage IVA Gallb...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Gallb...
Stage IVB Recta...
Unresectable Ex...
oxaliplatin
irinotecan hydr...
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Chicago View Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma NCT00084604 Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
irinotecan hydr...
bevacizumab
cisplatin
computed tomogr...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer NCT01178944 Adenocarcinoma ...
Esophageal Undi...
Gastric Adenoca...
Gastric Squamou...
Recurrent Esoph...
Recurrent Esoph...
Recurrent Gastr...
Stage IIIB Esop...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Esop...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Esopha...
Stage IV Gastri...
Undifferentiate...
Laboratory Biom...
Oxaliplatin
Pralatrexate
18 Years - Roswell Park Cancer Institute View A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer NCT00064259 Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Esoph...
Recurrent Gastr...
Squamous Cell C...
Stage III Esoph...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Gastri...
oblimersen sodi...
cisplatin
fluorouracil
19 Years - National Cancer Institute (NCI) View A Study of Creatine Combined With Curcumin in the Intervention of Early Cachexia in Upper Gastrointestinal Tumors NCT05856500 Stage IV Gastri...
Stage IIIA Gast...
Stage IIIB Gast...
Stage III Esoph...
Stage IV Esopha...
basic nutrition
oral supplement...
18 Years - 80 Years The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School View Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer NCT02333188 Adenocarcinoma ...
Adult Cholangio...
Gallbladder Car...
Gastric Adenoca...
Malignant Gastr...
Metastatic Panc...
Pancreatic Aden...
Stage III Ampul...
Stage III Pancr...
Stage IIIA Gall...
Stage IIIA Gast...
Stage IIIB Gall...
Stage IIIB Gast...
Stage IV Ampull...
Stage IV Gallbl...
Stage IV Gastri...
Stage IV Pancre...
Paclitaxel Albu...
Leucovorin Calc...
Irinotecan Hydr...
Fluorouracil
Laboratory Biom...
18 Years - University of Chicago View Fluorouracil, Cisplatin, Leucovorin Calcium, and Cetuximab in Treating Patients With Adenocarcinoma of the Stomach or Gastroesophageal Junction NCT01360086 Adenocarcinoma ...
Gastric Cancer
cetuximab
cisplatin
fluorouracil
leucovorin calc...
adjuvant therap...
neoadjuvant the...
quality-of-life...
therapeutic con...
18 Years - 75 Years Federation Francophone de Cancerologie Digestive View 64Cu DOTA-Trastuzumab PET/CT in Studying Patients With Gastric Cancer NCT01939275 Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IA Gastri...
Stage IB Gastri...
Stage IIA Gastr...
Stage IIB Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
copper Cu 64-DO...
positron emissi...
laboratory biom...
Computed Tomogr...
18 Years - City of Hope Medical Center View A Phase I/II Study of Oblimersen Plus Cisplatin and Fluorouracil in Gastric & Esophageal Junction Cancer NCT00064259 Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Esoph...
Recurrent Gastr...
Squamous Cell C...
Stage III Esoph...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Gastri...
oblimersen sodi...
cisplatin
fluorouracil
19 Years - National Cancer Institute (NCI) View Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer NCT00963092 Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
DNA analysis
RNA analysis
microarray anal...
protein analysi...
cytology specim...
laboratory biom...
questionnaire a...
16 Years - National Cancer Institute (NCI) View Pilot Trial of CRLX101 in Treatment of Patients With Advanced or Metastatic Stomach, Gastroesophageal, or Esophageal Cancer That Cannot be Removed by Surgery NCT01612546 Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Esoph...
Recurrent Gastr...
Squamous Cell C...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Gastri...
cyclodextrin-ba...
Laboratory biom...
Pharmacological...
18 Years - City of Hope Medical Center View Symptom Control With or Without Docetaxel in Treating Patients With Relapsed Esophageal Cancer or Stomach Cancer NCT00978549 Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
Nausea and Vomi...
Pain
docetaxel
steroid therapy
questionnaire a...
nausea and vomi...
pain therapy
quality-of-life...
standard follow...
radiation thera...
18 Years - National Cancer Institute (NCI) View Epirubicin Hydrochloride, Cisplatin, and Fluorouracil or Capecitabine With or Without Lapatinib Ditosylate as First-Line Therapy in Treating Patients With Stomach Cancer or Gastroesophageal Junction Cancer NCT01123473 Adenocarcinoma ...
Gastric Cancer
capecitabine
cisplatin
epirubicin hydr...
fluorouracil
lapatinib ditos...
18 Years - 75 Years European Organisation for Research and Treatment of Cancer - EORTC View S1201: Combination Chemo for Patients W/Advanced or Metastatic Esophageal, Gastric, or Gastroesophageal Junction Cancer NCT01498289 Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
FOLFOX regimen
docetaxel
fluorouracil
irinotecan hydr...
leucovorin calc...
oxaliplatin
18 Years - 120 Years SWOG Cancer Research Network View C-Met Inhibitor AMG 337, Oxaliplatin, Leucovorin Calcium, and Fluorouracil in Treating Patients With Advanced Stomach or Esophageal Cancer NCT02344810 Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Gastrointestina...
Intestinal Aden...
Mixed Adenocarc...
Stage IIIA Esop...
Stage IIIA Gast...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Gastri...
c-Met inhibitor...
placebo
oxaliplatin
leucovorin calc...
fluorouracil
pharmacological...
laboratory biom...
18 Years - Eastern Cooperative Oncology Group View Combination Chemotherapy With or Without Vismodegib in Treating Patients With Advanced Stomach Cancer or Gastroesophageal Junction Cancer NCT00982592 Adenocarcinoma ...
Adenocarcinoma ...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
oxaliplatin
leucovorin calc...
fluorouracil
placebo
vismodegib
laboratory biom...
18 Years - National Cancer Institute (NCI) View Study of Blood and Tissue Samples From Patients With Stomach Cancer, Esophageal Cancer, or Gastroesophageal Junction Cancer NCT00963092 Adenocarcinoma ...
Esophageal Canc...
Gastric Cancer
DNA analysis
RNA analysis
microarray anal...
protein analysi...
cytology specim...
laboratory biom...
questionnaire a...
16 Years - National Cancer Institute (NCI) View Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer NCT01212822 Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Squamous Cell C...
Stage IA Esopha...
Stage IA Gastri...
Stage IB Esopha...
Stage IB Gastri...
Stage IIA Esoph...
Stage IIA Gastr...
Stage IIB Esoph...
Stage IIB Gastr...
Stage IIIA Esop...
Stage IIIA Gast...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
therapeutic con...
laboratory biom...
18 Years - Fox Chase Cancer Center View Electronic Monitoring Device of Patient-Reported Outcomes and Function in Improving Patient-Centered Care in Patients With Gastrointestinal Cancer Undergoing Surgery NCT02511821 Stage I Adult L...
Stage I Colorec...
Stage IA Gastri...
Stage IA Pancre...
Stage IB Gastri...
Stage IB Pancre...
Stage II Adult ...
Stage IIA Color...
Stage IIA Gastr...
Stage IIA Pancr...
Stage IIB Color...
Stage IIB Gastr...
Stage IIB Pancr...
Stage IIC Color...
Stage III Pancr...
Stage IIIA Adul...
Stage IIIA Colo...
Stage IIIA Gast...
Stage IIIB Adul...
Stage IIIB Colo...
Stage IIIB Gast...
Stage IIIC Adul...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IV Gastri...
Stage IVA Color...
Stage IVA Liver...
Stage IVA Pancr...
Stage IVB Color...
Stage IVB Liver...
Stage IVB Pancr...
Computer-Assist...
Vivofit watch
Quality-of-Life...
Questionnaire A...
21 Years - City of Hope Medical Center View Irinotecan Hydrochloride With or Without Alvocidib in Treating Patients With Advanced Stomach or Gastroesophageal Junction Cancer That Cannot Be Removed By Surgery NCT00991952 Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
alvocidib
irinotecan hydr...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Irinotecan, Cisplatin, and Bevacizumab in Treating Patients With Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma NCT00084604 Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IIIA Gast...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
irinotecan hydr...
bevacizumab
cisplatin
computed tomogr...
laboratory biom...
18 Years - National Cancer Institute (NCI) View Genotype-guided Dosing of mFOLFIRINOX Chemotherapy in Patients With Previously Untreated Advanced Gastrointestinal Malignancies NCT01643499 Acinar Cell Ade...
Adenocarcinoma ...
Adenocarcinoma ...
Adult Primary C...
Advanced Adult ...
Cholangiocarcin...
Cholangiocarcin...
Diffuse Adenoca...
Duct Cell Adeno...
Intestinal Aden...
Localized Unres...
Metastatic Carc...
Metastatic Extr...
Mixed Adenocarc...
Mucinous Adenoc...
Mucinous Adenoc...
Newly Diagnosed...
Signet Ring Ade...
Signet Ring Ade...
Stage III Pancr...
Stage IIIA Colo...
Stage IIIA Gall...
Stage IIIA Gast...
Stage IIIA Rect...
Stage IIIB Colo...
Stage IIIB Gall...
Stage IIIB Gast...
Stage IIIB Rect...
Stage IIIC Colo...
Stage IIIC Gast...
Stage IIIC Rect...
Stage IV Gastri...
Stage IV Pancre...
Stage IVA Colon...
Stage IVA Gallb...
Stage IVA Recta...
Stage IVB Colon...
Stage IVB Gallb...
Stage IVB Recta...
Unresectable Ex...
oxaliplatin
irinotecan hydr...
leucovorin calc...
fluorouracil
laboratory biom...
18 Years - University of Chicago View Bevacizumab and Combination Chemotherapy Before Surgery in Treating Patients With Locally Advanced Esophageal or Stomach Cancer NCT01212822 Adenocarcinoma ...
Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Squamous Cell C...
Stage IA Esopha...
Stage IA Gastri...
Stage IB Esopha...
Stage IB Gastri...
Stage IIA Esoph...
Stage IIA Gastr...
Stage IIB Esoph...
Stage IIB Gastr...
Stage IIIA Esop...
Stage IIIA Gast...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Gast...
bevacizumab
oxaliplatin
leucovorin calc...
fluorouracil
therapeutic con...
laboratory biom...
18 Years - Fox Chase Cancer Center View Bortezomib With or Without Irinotecan in Treating Patients With Cancer of the Gastroesophageal Junction or Stomach NCT00061932 Adenocarcinoma ...
Diffuse Adenoca...
Intestinal Aden...
Mixed Adenocarc...
Recurrent Gastr...
Stage IIIB Gast...
Stage IIIC Gast...
Stage IV Gastri...
bortezomib
irinotecan
18 Years - National Cancer Institute (NCI) View Pralatrexate and Oxaliplatin in Treating Patients With Unresectable or Metastatic Esophageal, Stomach, or Gastroesophageal Junction Cancer NCT01178944 Adenocarcinoma ...
Esophageal Undi...
Gastric Adenoca...
Gastric Squamou...
Recurrent Esoph...
Recurrent Esoph...
Recurrent Gastr...
Stage IIIB Esop...
Stage IIIB Esop...
Stage IIIB Gast...
Stage IIIC Esop...
Stage IIIC Esop...
Stage IIIC Gast...
Stage IV Esopha...
Stage IV Esopha...
Stage IV Gastri...
Undifferentiate...
Laboratory Biom...
Oxaliplatin
Pralatrexate
18 Years - Roswell Park Cancer Institute View Oxaliplatin and S-1 or Oxaliplatin and Capecitabine in Treating Patients With Recurrent, Metastatic, or Unresectable Gastric Cancer NCT00985556 Gastric Cancer
capecitabine
oxaliplatin
tegafur-gimerac...
18 Years - National Cancer Institute (NCI) View